Brand Name
Natroba
Generic Name
Spinosad
View Brand Information FDA approval date: January 25, 2011
Classification: Pediculicide
Form: Suspension
What is Natroba (Spinosad)?
NATROBA is a pediculicide indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older.
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
Vision and Inflammation Study Testing Anti-acarid Therapeutics (VISTA-1): A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.
Summary: The purpose of this study is to establish the clinical efficacy of APT-001 topical therapy 1.8% in patients with blepharitis as compared to its vehicle control, and to establish that the therapeutic is safe and generally well tolerated by patients.